Journal:
:iranian journal of basic medical sciences
0
javid morad abbasi immunology research center, buali research institute, mashhad university of medical sciences, mashhad, iran
maryam rastin immunology research center, buali research institute, mashhad university of medical sciences, mashhad, iran
zahra rezaieyazdi rheumatic diseases research center, mashhad university of medical sciences, mashhad, iran
zahra mirfeizi rheumatic diseases research center, mashhad university of medical sciences, mashhad, iran
seyed-mohammad moazzeni department of immunology, school of medical sciences, tarbiat modares university, tehran, iran
nafise tabasi immunology research center, buali research institute, mashhad university of medical sciences, mashhad, iran
objective(s) recent studies on human indicate that the introduction of therapeutic use of tolerogenic dendritic cell (dc) for chronic inflammatory conditions is imminent. for the purpose of defining cgrp potency in tolerogenic dc production, we investigated the phenotype and il-'2 production of dcs generated from the monocytes of rheumatoid arthritis (ra) patients in the presence of the ca...
